Mercury Systems (MRCY) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Q3 FY25 revenue reached $211.4 million, up 1.5% year-over-year, with year-to-date revenue growth of 8.9%.
Backlog grew 4% year-over-year to $1.34 billion, with a trailing twelve-month book-to-bill ratio of 1.1.
Adjusted EBITDA was $24.7 million (11.7% margin), up from $(2.4) million last year; free cash flow improved to $24.1 million, up $49.8 million year-over-year.
GAAP net loss narrowed to $19.2 million ($0.33/share) from $44.6 million ($0.77/share) last year.
Significant contract wins in Common Processing Architecture and F-35 programs, plus acquisition of Star Lab and divestiture of Swiss manufacturing.
Financial highlights
Q3 FY25 revenue: $211.4 million (vs. $208.3 million Q3 FY24); year-to-date revenue: $638.9 million, up 8.9%.
Q3 FY25 gross margin: 27.0% (up from 19.5% year-over-year); adjusted EBITDA margin: 11.7%.
Q3 FY25 adjusted EPS: $0.06 (vs. $(0.26) Q3 FY24); GAAP net loss: $19.2 million.
Free cash flow for Q3 FY25: $24.1 million (vs. $(25.7) million Q3 FY24); $146 million generated over the last four quarters.
Cash and cash equivalents at quarter-end: $269.8 million; net debt at $322 million, lowest since Q1 FY22.
Outlook and guidance
FY25 revenue growth expected to approach mid-single digits, with Q4 revenue flat year-over-year due to accelerated deliveries in Q2.
Adjusted EBITDA margins for FY25 expected in low double digits, with Q4 margins approaching mid-teens.
Free cash flow for FY25 projected to exceed prior expectations, with Q4 around break-even.
Long-term targets: above-market revenue growth, adjusted EBITDA margins in low-to-mid-20% range, and 50% free cash flow conversion.
Management expects existing cash, revolver, and operations to cover anticipated needs for at least the next 12 months.
Latest events from Mercury Systems
- Record Q3 bookings and margin expansion drive improved FY26 outlook and strong cash position.MRCY
Q3 20266 May 2026 - Record backlog and strong cash flow highlight momentum and growth in defense technology.MRCY
Investor presentation16 Mar 2026 - Record backlog and margin expansion drive Q2 growth, improved profitability, and strong outlook.MRCY
Q2 20264 Feb 2026 - Record backlog and free cash flow support margin expansion and growth in FY25.MRCY
Q4 20241 Feb 2026 - Revenue up 13%, bookings up 29%, record backlog, and improved margins with positive outlook.MRCY
Q1 202516 Jan 2026 - Q2 FY25 saw 13% revenue growth, record free cash flow, and improved margins.MRCY
Q2 20259 Jan 2026 - Director elections, executive pay, new incentive plan, and auditor ratification headline the agenda.MRCY
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, with enhanced focus on pay-for-performance and ESG.MRCY
Proxy Filing1 Dec 2025 - Record bookings, margin expansion, and strong free cash flow set the stage for FY26 growth.MRCY
Q4 202523 Nov 2025